Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Breast 2Tumor-Agnostic 1Sarcoma 1Gynecologic 1

Conditions

Breast Neoplasms 2Hot Flashes 1

Interventions

Cyclophosphamide 423Trastuzumab 414Paclitaxel 375Docetaxel 314Capecitabine 266Letrozole 262Carboplatin 257Doxorubicin 213Tamoxifen 184Fulvestrant 176Epirubicin 176Radiotherapy 171Anastrozole 164pembrolizumab 152pertuzumab 147Surveys and Questionnaires 146Exercise 142exemestane 128Vinorelbine 127palbociclib 124Bevacizumab 123Magnetic Resonance Spectroscopy 120Blood Specimen Collection 120Drug Therapy 106Albumin-Bound Paclitaxel 105Gemcitabine 99130-nm albumin-bound paclitaxel 98pyrotinib 92eribulin 90Biopsy 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Mind-Body Therapies × Breast × Clear all
NCT02166983 2014-11-24

Cognitive Enhancement Program in Improving Cognitive Function in Breast Cancer Survivors

Stanford University

Phase NA Withdrawn
Breast

Breast Neoplasms

NCT00711529 2013-06-24

Pilot Study Comparing Hypnotherapy and Gabapentin for Hot Flashes.

Women and Infants Hospital of Rhode Island

Phase 3 Completed
27 enrolled 13 charts
Breast

Breast Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡